why choose us

First received: May 31, 2023

Clinical Trial: Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Signs and Symptoms of Dry Eye Disease

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Dry Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Multi-center, Randomized, Double-Masked, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Signs and Symptoms of Dry Eye Disease

Brief Summary: To evaluate the safety and efficacy of Licaminlimab for the treatment of signs of dry eye disease.

Read more